431 related articles for article (PubMed ID: 17270614)
1. Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction.
Kuo HC
Urology; 2007 Jan; 69(1):57-61; discussion 61-2. PubMed ID: 17270614
[TBL] [Abstract][Full Text] [Related]
2. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
Kuo HC
Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
[TBL] [Abstract][Full Text] [Related]
3. Satisfaction with urethral injection of botulinum toxin A for detrusor sphincter dyssynergia in patients with spinal cord lesion.
Kuo HC
Neurourol Urodyn; 2008; 27(8):793-6. PubMed ID: 18508331
[TBL] [Abstract][Full Text] [Related]
4. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection.
Kuo HC
Urology; 2008 Nov; 72(5):1056-60. PubMed ID: 18533231
[TBL] [Abstract][Full Text] [Related]
6. Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder.
Mokhless I; Gaafar S; Fouda K; Shafik M; Assem A
J Urol; 2006 Oct; 176(4 Pt 2):1767-70; discussion 1770. PubMed ID: 16945643
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction.
Pannek J; Göcking K; Bersch U
BJU Int; 2009 Nov; 104(9):1246-50. PubMed ID: 19426192
[TBL] [Abstract][Full Text] [Related]
8. Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity.
Karsenty G; Reitz A; Lindemann G; Boy S; Schurch B
Urology; 2006 Dec; 68(6):1193-7. PubMed ID: 17141831
[TBL] [Abstract][Full Text] [Related]
9. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
[TBL] [Abstract][Full Text] [Related]
10. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction.
Kuo HC
J Urol; 2003 Nov; 170(5):1908-12. PubMed ID: 14532805
[TBL] [Abstract][Full Text] [Related]
11. Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction.
Schulte-Baukloh H; Weiss C; Stolze T; Herholz J; Stürzebecher B; Miller K; Knispel HH
Eur Urol; 2005 Dec; 48(6):984-90; discussion 990. PubMed ID: 16126328
[TBL] [Abstract][Full Text] [Related]
12. Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics.
Kuo HC
Urology; 2005 Jul; 66(1):94-8. PubMed ID: 15992869
[TBL] [Abstract][Full Text] [Related]
13. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.
Franco I; Landau-Dyer L; Isom-Batz G; Collett T; Reda EF
J Urol; 2007 Oct; 178(4 Pt 2):1775-9; discussion 1779-80. PubMed ID: 17707430
[TBL] [Abstract][Full Text] [Related]
14. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
Sahai A; Sangster P; Kalsi V; Khan MS; Fowler CJ; Dasgupta P
BJU Int; 2009 Mar; 103(5):630-4. PubMed ID: 18990156
[TBL] [Abstract][Full Text] [Related]
15. Proposal for a urodynamic redefinition of detrusor underactivity.
Cucchi A; Quaglini S; Rovereto B
J Urol; 2009 Jan; 181(1):225-9. PubMed ID: 19013594
[TBL] [Abstract][Full Text] [Related]
16. [Botulinum A toxin in the treatment of patients with detrusor external sphincter dyssynergia and neurogenic low detrusor contractility].
Mazo EB; Krivoborodov GG; Efremov NS
Ter Arkh; 2008; 80(10):49-52. PubMed ID: 19105415
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
Gamé X; Castel-Lacanal E; Bentaleb Y; Thiry-Escudié I; De Boissezon X; Malavaud B; Marque P; Rischmann P
Eur Urol; 2008 Mar; 53(3):613-8. PubMed ID: 17804150
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of urethral injection of botulinum A toxin in the treatment of voiding dysfunction after radical hysterectomy.
Kuo HC
Urol Int; 2005; 75(3):247-51. PubMed ID: 16215314
[TBL] [Abstract][Full Text] [Related]
19. Effect of single botulinum toxin A injection to the external urethral sphincter for treating detrusor external sphincter dyssynergia in spinal cord injury.
Chen SL; Bih LI; Huang YH; Tsai SJ; Lin TB; Kao YL
J Rehabil Med; 2008 Oct; 40(9):744-8. PubMed ID: 18843427
[TBL] [Abstract][Full Text] [Related]
20. Sacral neuromodulation in women with idiopathic detrusor overactivity incontinence: decreased overactivity but unchanged bladder contraction strength and urethral resistance during voiding.
Groen J; Ruud Bosch JL; van Mastrigt R
J Urol; 2006 Mar; 175(3 Pt 1):1005-9; discussion 1009. PubMed ID: 16469603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]